We recommend against covering these medications for the same reasons we don't cover them with our fully insured book of business
For obesity therapeutics, Phase 3 trials are especially important because regulators want to see: Long-term weight loss sustainability Cardiovascular safety Real-world tolerability Effects on obesity-related conditions such as diabetes, sleep apnea, and osteoarthritis Retatrutides Phase 3 program, called TRIUMPH , includes multiple large-scale studies across different patient populations
In esophageal injury models, BPC-157 demonstrated faster closure of experimentally induced ulcers compared to omeprazole (a standard PPI) at 14 days
If you dont see any results from Wegovy after a few weeks, its important to stay patient, as weight loss with the medication can take time
Accurate structure prediction of biomolecular interactions with AlphaFold 3
Fried foods cause particular problems